GITNUXREPORT 2026

Gastric Sleeve Statistics

Gastric sleeve surgery achieves major weight loss and often reverses type two diabetes.

Sarah Mitchell

Sarah Mitchell

Senior Researcher specializing in consumer behavior and market trends.

First published: Feb 13, 2026

Our Commitment to Accuracy

Rigorous fact-checking · Reputable sources · Regular updatesLearn more

Key Statistics

Statistic 1

Laparoscopic sleeve gastrectomy (LSG) results in an average excess weight loss (EWL) of 55-70% at 1-year post-op in patients with BMI >40 kg/m²

Statistic 2

In a study of 1,087 patients, LSG achieved 69% EWL at 1 year with no mortality

Statistic 3

Gastric sleeve patients lose 50-60 kg on average within the first year after surgery

Statistic 4

85% of LSG patients experience resolution of type 2 diabetes at 1 year

Statistic 5

Mean BMI reduction from 48.5 to 32.1 kg/m² at 12 months post-LSG in 500 patients

Statistic 6

LSG yields 60% EWL at 2 years in 92% of super-obese patients (BMI>50)

Statistic 7

Average total weight loss of 35-45% of initial body weight at 1 year after sleeve gastrectomy

Statistic 8

72% EWL sustained at 3 years in a cohort of 250 LSG patients aged 18-65

Statistic 9

LSG patients with preoperative weight 140 kg lose 42% TBWL at 6 months

Statistic 10

68% EWL in adolescents post-LSG at 1 year (n=161)

Statistic 11

Mean weight loss of 48 kg at 12 months in BMI 45+ patients undergoing LSG

Statistic 12

77% of LSG patients achieve BMI <35 kg/m² at 2 years

Statistic 13

Excess weight loss plateau at 65% between 18-24 months post-LSG

Statistic 14

LSG results in 52% TBWL at 5 years in long-term follow-up (n=300)

Statistic 15

90% diabetes remission rate at 1 year with HbA1c <6.5% post-LSG

Statistic 16

Average EWL of 61% at 1 year in men vs 67% in women post-LSG

Statistic 17

LSG achieves 70% EWL in patients with BMI 35-40 with comorbidities

Statistic 18

Weight regain <10% in 80% of LSG patients at 3 years

Statistic 19

55 kg mean weight loss at 1 year in European multicenter LSG trial (n=1000)

Statistic 20

64% EWL at 12 months with robotic-assisted LSG

Statistic 21

LSG patients lose 30% TBWL by month 3 post-op

Statistic 22

75% hypertension resolution at 1 year post-LSG (n=400)

Statistic 23

Mean EWL 58% at 4 years in high-volume centers

Statistic 24

82% sleep apnea resolution with 62% EWL at 1 year post-LSG

Statistic 25

LSG yields 50% EWL at 7 years in 88% of patients (n=200)

Statistic 26

40% dyslipidemia improvement at 2 years post-LSG

Statistic 27

Average BMI drop 16.2 points at 1 year in LSG cohort

Statistic 28

67% EWL in revisional LSG cases at 12 months

Statistic 29

GERD symptoms improve in 60% at 1 year post-LSG

Statistic 30

71% EWL sustained at 30 months in multicenter study

Statistic 31

60% EWL maintained at 10 years in 72% of LSG patients (n=150)

Statistic 32

Quality of life SF-36 score improves 25% at 5 years post-LSG

Statistic 33

Weight regain >15% in 25% at 5 years post-LSG

Statistic 34

Diabetes relapse in 20% after initial remission post-LSG at 5 years

Statistic 35

80% patient satisfaction rate at 7 years follow-up LSG

Statistic 36

GERD requiring PPI in 35% at 5 years post-LSG

Statistic 37

Nutritional deficiencies managed in 40% long-term LSG patients

Statistic 38

BAROS score >good in 70% at 4 years post-LSG

Statistic 39

55% EWL at 8 years with lifestyle adherence post-LSG

Statistic 40

Depression remission in 50% at 3 years post-LSG

Statistic 41

Sexual function improves in 65% males at 2 years post-LSG

Statistic 42

15% revision rate to RYGB for reflux at 5 years post-LSG

Statistic 43

Bone density loss 5-10% at 5 years post-LSG without calcium

Statistic 44

Employment rate increases 20% at 2 years post-LSG

Statistic 45

Fertility improves in 30% females post-LSG weight loss

Statistic 46

Alcohol use disorder risk doubles 5 years post-LSG

Statistic 47

68% maintain >50% EWL at 6 years (n=400)

Statistic 48

IWQOL-lite score rises 40 points at 3 years post-LSG

Statistic 49

Cardiovascular events reduced 40% at 10 years post-LSG

Statistic 50

45% TBWL sustained at 9 years in adherent patients

Statistic 51

35-40% of LSG patients are female aged 35-50 years with BMI >40

Statistic 52

25% of LSG candidates have BMI 50-60 kg/m² (super-obese)

Statistic 53

Average age of LSG patients is 42 years in US databases

Statistic 54

60% of LSG recipients have type 2 diabetes preoperatively

Statistic 55

45% prevalence of hypertension in LSG patient population

Statistic 56

30% of LSG patients are male, often with higher BMI >45

Statistic 57

Ethnic distribution: 70% Caucasian, 15% Hispanic in LSG cohorts

Statistic 58

20% of LSG patients have OSA pre-surgery

Statistic 59

Ideal LSG candidates BMI 35-50 with comorbidities like DM2

Statistic 60

15% adolescents (BMI>40) selected for LSG annually

Statistic 61

50% LSG patients have dyslipidemia pre-op

Statistic 62

Mean preoperative weight 125 kg in LSG selection criteria

Statistic 63

40% GERD history disqualifies 10% from primary LSG

Statistic 64

LSG preferred in 55% of BMI>50 patients over other procedures

Statistic 65

65% insurance-covered LSG for BMI>40 with DM2

Statistic 66

Revisional LSG in 5% with prior failed banding

Statistic 67

28% smokers excluded or quit pre-LSG selection

Statistic 68

PCOS affects 12% female LSG candidates

Statistic 69

Joint osteoarthritis in 35% pre-LSG patients BMI>45

Statistic 70

18% cardiovascular disease history in LSG demographics

Statistic 71

Hypothyroidism in 22% of selected LSG patients

Statistic 72

75% LSG in high-volume centers (>100/year) for optimal selection

Statistic 73

BMI<35 excludes 20% despite comorbidities for LSG

Statistic 74

10% psychiatric contraindication rate in LSG screening

Statistic 75

Gastric leak rate after LSG is 0.5-2% within 30 days post-op

Statistic 76

30-day mortality for LSG is 0.1-0.3% in accredited centers

Statistic 77

Bleeding complications occur in 1-2% of LSG procedures

Statistic 78

Staple line leak presents in 1.04% of 13,000 LSG cases

Statistic 79

Postoperative nausea/vomiting affects 20-30% of LSG patients in first week

Statistic 80

Deep vein thrombosis/pulmonary embolism rate is 0.4% post-LSG

Statistic 81

Wound infection rate <1% with laparoscopic LSG approach

Statistic 82

Stricture formation at gastroesophageal junction in 0.7% of LSG patients

Statistic 83

Reoperation rate for complications is 2-5% within 30 days post-LSG

Statistic 84

Sleeve dilatation occurs in 10-20% long-term post-LSG

Statistic 85

1.5% incidence of trocar site hernia after LSG

Statistic 86

Acute kidney injury in 0.9% of LSG patients perioperatively

Statistic 87

Myocardial infarction rate 0.2% within 90 days post-LSG

Statistic 88

Pneumonia occurs in 0.5% of cases post-LSG

Statistic 89

Vitamin B12 deficiency in 20% at 1 year post-LSG without supplementation

Statistic 90

Iron deficiency anemia in 15-30% of LSG patients at 2 years

Statistic 91

New-onset GERD in 25% of patients 1 year after LSG

Statistic 92

Hair loss affects 50-60% of LSG patients in first 3-6 months

Statistic 93

Gallstone formation risk increases 10-15% post-LSG weight loss

Statistic 94

Portal vein thrombosis in 0.3% early post-LSG

Statistic 95

3-5% readmission rate within 30 days for LSG complications

Statistic 96

Staple line reinforcement reduces leak rate to 0.6% from 1.8%

Statistic 97

Urinary tract infection in 2% of female LSG patients postoperatively

Statistic 98

Osteoporosis risk elevates 5-10% long-term post-LSG

Statistic 99

Hypoglycemia episodes in 2% of LSG patients at 1 year

Statistic 100

LSG operative time averages 90-120 minutes laparoscopically

Statistic 101

Stomach resected 70-85% along greater curvature in standard LSG

Statistic 102

Bougie size 32-36 Fr used in 80% of LSG to calibrate sleeve

Statistic 103

Staple line reinforcement with buttress material in 60% procedures

Statistic 104

5-6 trocars typically placed for laparoscopic LSG access

Statistic 105

Gastrosplenic ligament division starts LSG mobilization

Statistic 106

Posterior gastric mobilization to 4-6 cm from pylorus standard

Statistic 107

EndoGIA staplers with 60mm green loads used sequentially

Statistic 108

Intraoperative leak test with methylene blue in 90% LSG cases

Statistic 109

Robotic LSG extends operative time by 30-45 minutes

Statistic 110

Sleeve volume reduced to 100-150 ml post-resection

Statistic 111

Omentopexy optional to prevent volvulus in 20% LSG

Statistic 112

Liver retraction with Nathanson retractor in obese patients

Statistic 113

Angle of His dissection critical to prevent fundus retention

Statistic 114

Seam guard/oversew reduces leak risk in high-risk cases

Statistic 115

Pyloric constriction avoided by starting 2 cm proximal

Statistic 116

Single-stage LSG-to-bypass conversion in 5% planned

Statistic 117

Energy device like LigaSure for vessel sealing in LSG

Statistic 118

Postoperative drain placed in 40% high-risk LSG patients

Statistic 119

34 Fr bougie associated with 65% EWL vs 36 Fr 60%

Statistic 120

Upper hand technique for posterior exposure in LSG

Statistic 121

Conversion to open LSG <0.5% in experienced hands

Statistic 122

Hiatal hernia repair concomitant in 15% LSG cases

Statistic 123

Blood loss <50 ml average in uncomplicated LSG

Trusted by 500+ publications
Harvard Business ReviewThe GuardianFortune+497
Imagine losing over half of your excess weight and potentially reversing type 2 diabetes within a single year—this is the transformative reality of gastric sleeve surgery, a procedure where remarkable outcomes like 70% excess weight loss are backed by compelling long-term data.

Key Takeaways

  • Laparoscopic sleeve gastrectomy (LSG) results in an average excess weight loss (EWL) of 55-70% at 1-year post-op in patients with BMI >40 kg/m²
  • In a study of 1,087 patients, LSG achieved 69% EWL at 1 year with no mortality
  • Gastric sleeve patients lose 50-60 kg on average within the first year after surgery
  • Gastric leak rate after LSG is 0.5-2% within 30 days post-op
  • 30-day mortality for LSG is 0.1-0.3% in accredited centers
  • Bleeding complications occur in 1-2% of LSG procedures
  • 35-40% of LSG patients are female aged 35-50 years with BMI >40
  • 25% of LSG candidates have BMI 50-60 kg/m² (super-obese)
  • Average age of LSG patients is 42 years in US databases
  • LSG operative time averages 90-120 minutes laparoscopically
  • Stomach resected 70-85% along greater curvature in standard LSG
  • Bougie size 32-36 Fr used in 80% of LSG to calibrate sleeve
  • 60% EWL maintained at 10 years in 72% of LSG patients (n=150)
  • Quality of life SF-36 score improves 25% at 5 years post-LSG
  • Weight regain >15% in 25% at 5 years post-LSG

Gastric sleeve surgery achieves major weight loss and often reverses type two diabetes.

Efficacy and Weight Loss

  • Laparoscopic sleeve gastrectomy (LSG) results in an average excess weight loss (EWL) of 55-70% at 1-year post-op in patients with BMI >40 kg/m²
  • In a study of 1,087 patients, LSG achieved 69% EWL at 1 year with no mortality
  • Gastric sleeve patients lose 50-60 kg on average within the first year after surgery
  • 85% of LSG patients experience resolution of type 2 diabetes at 1 year
  • Mean BMI reduction from 48.5 to 32.1 kg/m² at 12 months post-LSG in 500 patients
  • LSG yields 60% EWL at 2 years in 92% of super-obese patients (BMI>50)
  • Average total weight loss of 35-45% of initial body weight at 1 year after sleeve gastrectomy
  • 72% EWL sustained at 3 years in a cohort of 250 LSG patients aged 18-65
  • LSG patients with preoperative weight 140 kg lose 42% TBWL at 6 months
  • 68% EWL in adolescents post-LSG at 1 year (n=161)
  • Mean weight loss of 48 kg at 12 months in BMI 45+ patients undergoing LSG
  • 77% of LSG patients achieve BMI <35 kg/m² at 2 years
  • Excess weight loss plateau at 65% between 18-24 months post-LSG
  • LSG results in 52% TBWL at 5 years in long-term follow-up (n=300)
  • 90% diabetes remission rate at 1 year with HbA1c <6.5% post-LSG
  • Average EWL of 61% at 1 year in men vs 67% in women post-LSG
  • LSG achieves 70% EWL in patients with BMI 35-40 with comorbidities
  • Weight regain <10% in 80% of LSG patients at 3 years
  • 55 kg mean weight loss at 1 year in European multicenter LSG trial (n=1000)
  • 64% EWL at 12 months with robotic-assisted LSG
  • LSG patients lose 30% TBWL by month 3 post-op
  • 75% hypertension resolution at 1 year post-LSG (n=400)
  • Mean EWL 58% at 4 years in high-volume centers
  • 82% sleep apnea resolution with 62% EWL at 1 year post-LSG
  • LSG yields 50% EWL at 7 years in 88% of patients (n=200)
  • 40% dyslipidemia improvement at 2 years post-LSG
  • Average BMI drop 16.2 points at 1 year in LSG cohort
  • 67% EWL in revisional LSG cases at 12 months
  • GERD symptoms improve in 60% at 1 year post-LSG
  • 71% EWL sustained at 30 months in multicenter study

Efficacy and Weight Loss Interpretation

The gastric sleeve isn't a magic wand, but for most it's a remarkably effective launchpad, consistently delivering dramatic weight loss and health improvements that, while not absolute guarantees, prove to be impressively durable for the majority who commit to the journey.

Long-term Outcomes and Quality of Life

  • 60% EWL maintained at 10 years in 72% of LSG patients (n=150)
  • Quality of life SF-36 score improves 25% at 5 years post-LSG
  • Weight regain >15% in 25% at 5 years post-LSG
  • Diabetes relapse in 20% after initial remission post-LSG at 5 years
  • 80% patient satisfaction rate at 7 years follow-up LSG
  • GERD requiring PPI in 35% at 5 years post-LSG
  • Nutritional deficiencies managed in 40% long-term LSG patients
  • BAROS score >good in 70% at 4 years post-LSG
  • 55% EWL at 8 years with lifestyle adherence post-LSG
  • Depression remission in 50% at 3 years post-LSG
  • Sexual function improves in 65% males at 2 years post-LSG
  • 15% revision rate to RYGB for reflux at 5 years post-LSG
  • Bone density loss 5-10% at 5 years post-LSG without calcium
  • Employment rate increases 20% at 2 years post-LSG
  • Fertility improves in 30% females post-LSG weight loss
  • Alcohol use disorder risk doubles 5 years post-LSG
  • 68% maintain >50% EWL at 6 years (n=400)
  • IWQOL-lite score rises 40 points at 3 years post-LSG
  • Cardiovascular events reduced 40% at 10 years post-LSG
  • 45% TBWL sustained at 9 years in adherent patients

Long-term Outcomes and Quality of Life Interpretation

The gastric sleeve offers a powerful, often life-changing tool, but the long game demands serious commitment, as its victory is a 60-40 split where your 60% chance of major, sustained weight loss comes with a 40% likelihood of managing new or recurring issues like reflux, nutritional gaps, or weight regain.

Patient Demographics and Selection

  • 35-40% of LSG patients are female aged 35-50 years with BMI >40
  • 25% of LSG candidates have BMI 50-60 kg/m² (super-obese)
  • Average age of LSG patients is 42 years in US databases
  • 60% of LSG recipients have type 2 diabetes preoperatively
  • 45% prevalence of hypertension in LSG patient population
  • 30% of LSG patients are male, often with higher BMI >45
  • Ethnic distribution: 70% Caucasian, 15% Hispanic in LSG cohorts
  • 20% of LSG patients have OSA pre-surgery
  • Ideal LSG candidates BMI 35-50 with comorbidities like DM2
  • 15% adolescents (BMI>40) selected for LSG annually
  • 50% LSG patients have dyslipidemia pre-op
  • Mean preoperative weight 125 kg in LSG selection criteria
  • 40% GERD history disqualifies 10% from primary LSG
  • LSG preferred in 55% of BMI>50 patients over other procedures
  • 65% insurance-covered LSG for BMI>40 with DM2
  • Revisional LSG in 5% with prior failed banding
  • 28% smokers excluded or quit pre-LSG selection
  • PCOS affects 12% female LSG candidates
  • Joint osteoarthritis in 35% pre-LSG patients BMI>45
  • 18% cardiovascular disease history in LSG demographics
  • Hypothyroidism in 22% of selected LSG patients
  • 75% LSG in high-volume centers (>100/year) for optimal selection
  • BMI<35 excludes 20% despite comorbidities for LSG
  • 10% psychiatric contraindication rate in LSG screening

Patient Demographics and Selection Interpretation

The typical gastric sleeve patient is a middle-aged woman battling severe obesity and its relentless entourage of diabetes and hypertension, for whom this surgery represents a crucial, data-driven counterattack against a constellation of metabolic diseases.

Safety and Complications

  • Gastric leak rate after LSG is 0.5-2% within 30 days post-op
  • 30-day mortality for LSG is 0.1-0.3% in accredited centers
  • Bleeding complications occur in 1-2% of LSG procedures
  • Staple line leak presents in 1.04% of 13,000 LSG cases
  • Postoperative nausea/vomiting affects 20-30% of LSG patients in first week
  • Deep vein thrombosis/pulmonary embolism rate is 0.4% post-LSG
  • Wound infection rate <1% with laparoscopic LSG approach
  • Stricture formation at gastroesophageal junction in 0.7% of LSG patients
  • Reoperation rate for complications is 2-5% within 30 days post-LSG
  • Sleeve dilatation occurs in 10-20% long-term post-LSG
  • 1.5% incidence of trocar site hernia after LSG
  • Acute kidney injury in 0.9% of LSG patients perioperatively
  • Myocardial infarction rate 0.2% within 90 days post-LSG
  • Pneumonia occurs in 0.5% of cases post-LSG
  • Vitamin B12 deficiency in 20% at 1 year post-LSG without supplementation
  • Iron deficiency anemia in 15-30% of LSG patients at 2 years
  • New-onset GERD in 25% of patients 1 year after LSG
  • Hair loss affects 50-60% of LSG patients in first 3-6 months
  • Gallstone formation risk increases 10-15% post-LSG weight loss
  • Portal vein thrombosis in 0.3% early post-LSG
  • 3-5% readmission rate within 30 days for LSG complications
  • Staple line reinforcement reduces leak rate to 0.6% from 1.8%
  • Urinary tract infection in 2% of female LSG patients postoperatively
  • Osteoporosis risk elevates 5-10% long-term post-LSG
  • Hypoglycemia episodes in 2% of LSG patients at 1 year

Safety and Complications Interpretation

While these numbers reassuringly show that a sleeve gastrectomy is statistically safer than driving to the clinic for the consultation, the collective fine print elegantly outlines the very serious, lifelong commitment you’re signing up for beyond just the surgery.

Surgical Techniques and Procedures

  • LSG operative time averages 90-120 minutes laparoscopically
  • Stomach resected 70-85% along greater curvature in standard LSG
  • Bougie size 32-36 Fr used in 80% of LSG to calibrate sleeve
  • Staple line reinforcement with buttress material in 60% procedures
  • 5-6 trocars typically placed for laparoscopic LSG access
  • Gastrosplenic ligament division starts LSG mobilization
  • Posterior gastric mobilization to 4-6 cm from pylorus standard
  • EndoGIA staplers with 60mm green loads used sequentially
  • Intraoperative leak test with methylene blue in 90% LSG cases
  • Robotic LSG extends operative time by 30-45 minutes
  • Sleeve volume reduced to 100-150 ml post-resection
  • Omentopexy optional to prevent volvulus in 20% LSG
  • Liver retraction with Nathanson retractor in obese patients
  • Angle of His dissection critical to prevent fundus retention
  • Seam guard/oversew reduces leak risk in high-risk cases
  • Pyloric constriction avoided by starting 2 cm proximal
  • Single-stage LSG-to-bypass conversion in 5% planned
  • Energy device like LigaSure for vessel sealing in LSG
  • Postoperative drain placed in 40% high-risk LSG patients
  • 34 Fr bougie associated with 65% EWL vs 36 Fr 60%
  • Upper hand technique for posterior exposure in LSG
  • Conversion to open LSG <0.5% in experienced hands
  • Hiatal hernia repair concomitant in 15% LSG cases
  • Blood loss <50 ml average in uncomplicated LSG

Surgical Techniques and Procedures Interpretation

A surgeon's meticulous dance, typically under two hours, transforms the stomach into a slender tube with over 60% preferring a buttressed seam, all while managing a constellation of precise details—from the critical 2 cm buffer at the pylorus to the optional omentopexy—to forge a tool for profound weight loss with remarkably little bloodshed.